Skip to main content

Study of Single-Chamber Leadless Pacemaker Sets Stage for Two-Chamber System

title

A study showing the safety and effectiveness of a leadless cardiac pacemaker for right ventricular pacing has set the stage for research into a novel dual-chamber device that would serve a significantly broader population of patients with abnormal heart rhythms. A global clinical trial of the first-in-human dual chamber system is now enrolling, with Mount Sinai as a key investigative site.

Referring a patient is easy. Just click the “Refer a Patient Online” button.

Learn More